TSC Ratings provides exclusive stock, ETF and mutual fund recommendations using proprietary tools. Our "safety-first" approach aims to reduce risk while achieving performance on a total return basis.
The following large-cap companies have market values of more than $10 billion and receive "buy" ratings from our proprietary quantitative model, which considers more than 60 factors. The stocks are ordered by their potential to appreciate.
franchises and operates hamburger restaurants worldwide.
: First-quarter revenue declined 10% to $5.07 billion but net income increased marginally to $980 million and earnings per share jumped 7% to 87 cents. Net margin remained strong at 20%. A 32% decline in the cash balance to $1.98 billion is a weakness. But a quick ratio of 1.3 and a debt-to-equity ratio of 0.8 indicate a conservative financial position.
: McDonald's has declined 8% in 2009, underperforming the
Dow Jones Industrial Average
. The stock trades at a price-to-earnings ratio of 15 and offers a dividend yield of 3.5%.
makes and markets consumer products worldwide.
: First-quarter revenue decreased 6% to $3.5 billion but net income climbed 9% to $508 million as earnings per share jumped 13% to 97 cents. The company has established a five-quarter streak of earnings growth despite recessionary pressures. Gross margin increased and is high at 60%. Net operating cash flow ascended 21% as the cash balance improved 9% to $702 million.
: Colgate-Palmolive has climbed 6% in 2009, outperforming the Dow and the S&P 500. The stock trades at a price-to-earnings ratio of 20 and offers a 2.4% dividend yield.
Medco Health Solutions
is one of the nation's largest pharmacy-benefit managers, providing sophisticated traditional and specialty benefit programs.
: First-quarter revenue rose 14% to $14.8 billion, beating the industry average growth rate of 1.1%. Net income increased 8% to $291 million and earnings per share improved 16% to 58 cents. Net operating cash flow increased 607%. The company has added $1.3 billion to the cash balance since the prior year's first quarter.
: Medco has ascended 13% in 2009, outperforming the Dow and the S&P 500. The stock is trading at a price-to-earnings ratio of 21 and doesn't pay dividends.
develops and sells database, middleware and application software worldwide.
: Fiscal fourth-quarter revenue declined 5.2% to $6.9 billion as net income fell 7.2% to $1.9 billion. But earnings per share decreased just 2.5% on a lower share count. Operating margin improved to 43% as net margin dropped to 28%. The company holds nearly $13 billion of cash reserves, amounting to a quick ratio of 1.9. And its debt-to-equity ratio is conservative at 0.4.
: Oracle has increased 15% in 2009, outperforming all major U.S. indexes. The stock trades at a price-to-earnings ratio of 19 and doesn't consistently pay dividends.
Enterprise Products Partners
is a midstream energy company that provides services to producers and consumers of natural gas, NGLs, crude oil and petrochemicals in the U.S., Canada and Gulf of Mexico.
: First-quarter revenue fell 40% to $3.4 billion as net income weakened 13% to $225 million and earnings per share fell 20% to 41 cents. A quick ratio of 0.6 and a debt-to-equity ratio of 1.5 indicate a less-than-ideal financial position. However, margins improved significantly during the quarter, with operating margin climbing to 11% and net margin jumping to 6.6%.
: Enterprise Products has climbed 26% in 2009, outperforming all major U.S. indexes. Yet, at its current price, the stock still offers a cash distribution yield of 8.2%. Cash distributions are taxed differently than dividends.
TSC Ratings was given an award for "Best Stock Selection" among independent research providers by BNY ConvergEx Group. To see how your portfolio can utilize our research,
A rating can be viewed for any stock through our screener
. Each rating is derived from a variety of fundamental and pricing figures and represents our opinion of risk-adjusted performance relative to a 5,000+ stock coverage universe. However, the rating does not incorporate all factors that can alter a stock's performance, such as corporate or industry events, technology innovations and shifts in competitive dynamics.